Nefiracetam
From €39.80
Nefiracetam is a synthetic nootropic compound belonging to the racetam family, researched for its potential to enhance memory, learning, and cognitive function. It is also investigated for its neuroprotective properties and potential anxiolytic effects through modulation of neurotransmitter systems.
For a more detailed description and lab analysis, please see the sections below.

SAFE & SECURE CHECKOUT

PURE & TESTED
3rd Party lab tested

LAB TESTED
100% SATISFACTION GUARANTEED

Description
Nefiracetam, Powder
A Neuroscientist’s Deep Dive into One of the Most Fascinating Racetams
What Is Nefiracetam?
Nefiracetam (also known as Nefiracetam HBr or NS-105) belongs to the racetam family—a class of synthetic compounds renowned for their cognitive-enhancing properties. While its cousin piracetam gets most of the spotlight, nefiracetam occupies a unique niche in the nootropic world due to its dual mechanism of action and its pronounced anxiolytic (anxiety-reducing) and neuroprotective effects.
Developed in the early 1990s by Daiichi Pharmaceutical Co. in Japan, nefiracetam was originally investigated as a treatment for post-stroke cognitive decline and Alzheimer’s disease. Today, it’s prized by researchers and enthusiasts alike for its distinct pharmacological profile that sets it apart from every other racetam on the market.
The Science: How Nefiracetam Works
Understanding nefiracetam requires a brief tour of your brain’s communication systems. Neurons communicate via chemical messengers called neurotransmitters, which bind to receptor proteins on neighboring neurons. Two of the most important receptor systems in the brain are:
| Receptor System | Normal Function | Nefiracetam’s Effect |
|---|---|---|
| AMPA receptors | Fast excitatory signaling; memory formation | Positive allosteric modulation (enhances signaling) |
| GABA_A receptors | Inhibitory signaling; dampens neural activity | Positive allosteric modulation (enhances calming) |
| Muscarinic acetylcholine receptors | Attention, learning, memory consolidation | Indirect potentiation via increased ACh release |
The Dual Modulation Paradox
Here’s what makes nefiracetam genuinely unique: it simultaneously enhances both excitatory (AMPA) and inhibitory (GABA_A) signaling. This sounds contradictory at first—like stepping on the gas and the brake at once. But in practice, this dual modulation produces a normalizing effect on neural circuits:
- In overactive circuits (anxiety, stress states), the GABA_A enhancement calms excessive firing.
- In underactive circuits (fatigue, cognitive decline), the AMPA enhancement boosts signal fidelity.
The result is not a blunt stimulant effect, but rather a homeostatic rebalancing of neural activity. This explains why nefiracetam is reported to reduce anxiety without sedation, while also sharpening focus without jitteriness.
Cholinergic Amplification
Nefiracetam also indirectly boosts the cholinergic system by enhancing the release of acetylcholine (ACh) in the hippocampus and cortex—brain regions critical for learning and memory. This is achieved through its actions on voltage-dependent calcium channels, which trigger greater neurotransmitter release per action potential.
The 30-Second Takeaway: Nefiracetam doesn’t create a new cognitive state—it optimizes the one you already have by making both excitatory and inhibitory synaptic transmission more efficient where needed.
What Are Researchers Investigating?
Based on both the preclinical literature and user reports, nefiracetam is associated with the following effects:
🧠 Cognitive Enhancement
- Improved working memory — better retention of information across short time windows
- Enhanced verbal fluency — smoother recall and articulation
- Sharper pattern recognition — improved ability to spot connections between ideas
🧘 Anxiolytic Effects
- Reduced social anxiety — many users report feeling more comfortable in social settings
- Diminished rumination — less mental looping on negative thoughts
- Calm focus — a state described as “relaxed alertness” rather than sedation
🛡️ Neuroprotection
Preclinical studies have demonstrated nefiracetam’s ability to:
- Protect hippocampal neurons from ischemic damage (stroke models)
- Enhance nerve growth factor (NGF) signaling
- Support long-term potentiation (LTP)—the cellular basis of memory formation
⏱️ Long-Lasting Effects
With a half-life of approximately 8–12 hours, nefiracetam provides sustained activity with a single daily dose—longer than piracetam (4–5 hours) or aniracetam (2–3 hours).
Dosing & Administration
Recommended Starting Protocol
| Phase | Dose | Frequency | Duration |
|---|---|---|---|
| Week 1 (Loading) | 100–200 mg | Twice daily | 7 days |
| Week 2 (Titration) | 200–300 mg | Twice daily | 7 days |
| Maintenance | 300–400 mg | Twice daily | As needed |
Total daily range: 200–800 mg, with 400–600 mg/day being the most commonly reported sweet spot.
Practical Notes for the Lab:
- With a meal: Absorption is significantly improved when taken with food, especially food containing healthy fats.
- Choline consideration: In research contexts involving racetams, co-administration with a choline source (like Alpha-GPC) is common to support cholinergic pathways and prevent potential headaches.
- Cycling: Many researchers recommend a “5 days on, 2 days off” schedule to observe the compound’s effects without building tolerance to its modulating properties.
- Powder handling — use a milligram-accurate scale; a standard 1/4 tsp scoop is not precise enough for racetam dosing
Stacking Considerations
Nefiracetam combines well with complementary compounds:
- With a choline source (Alpha-GPC, Citicoline): Prevents potential headaches from increased ACh demand
- With piracetam or oxiracetam: Creates a broad-spectrum nootropic base (though start with one at a time)
- With l-theanine: Synergistic calming effects for anxiety-prone individuals
Avoid stacking with:
- Other positive GABA_A modulators (benzodiazepines, alcohol, phenibut) — risk of excessive sedation
- Strong dopaminergic stimulants — potential for overstimulation as nefiracetam removes natural braking
Safety Profile & Side Effects
Preclinical Safety Data
Nefiracetam has an impressive safety margin in animal studies, with a therapeutic index exceeding 800:1 (the toxic dose is more than 800 times the effective dose in rodent models).
Reported Side Effects (rare, generally mild)
| Side Effect | Frequency | Notes |
|---|---|---|
| Mild headache | Uncommon | Usually resolves with choline supplementation |
| Mild GI upset | Rare | Often dose-dependent; take with food |
| Insomnia | Rare | Avoid late-day dosing |
| Mild overstimulation | Rare | More common in sensitive individuals |
Important Safety Considerations
⚠️ Cardiac Note: Nefiracetam interacts with hERG potassium channels. While standard nootropic doses (200–800 mg/day) are well-tolerated, individuals with pre-existing cardiac conditions (prolonged QT interval, arrhythmias) should exercise caution and consult a physician. To date, no clinically significant cardiac events have been reported at standard doses.
Nefiracetam vs. Other Racetams
| Property | Nefiracetam | Piracetam | Aniracetam | Pramiracetam |
|---|---|---|---|---|
| Primary mechanism | AMPA + GABA_A modulation | AMPA modulation | AMPA modulation | Cholinergic enhancement |
| Anxiolytic effect | Strong | Mild | Moderate | Minimal |
| Half-life | 8–12 hours | 4–5 hours | 2–3 hours | 4–6 hours |
| Choline demand | Moderate | Moderate | High | High |
| Onset of effects | 1–2 hours | Gradual | 30–60 min | 1 hour |
Bottom line: Choose nefiracetam when you want “calm focus” with neuroprotective support. Choose piracetam for broad-spectrum baseline cognitive support. Choose aniracetam for creative flow states.
Our Product Information
Nefiracetam Powder — 10g
Purity: ≥99% (HPLC verified)
Form: White crystalline powder
Solubility: Slightly soluble in water (improved with warm water or ethanol); best taken orally with juice or mixed into beverages
Storage: Cool, dry, dark place; airtight container; stable for 24+ months under proper conditions
Third-Party Testing
Every batch is tested via High-Performance Liquid Chromatography (HPLC) and mass spectrometry for:
- Identity confirmation
- Purity analysis (≥99%)
- Residual solvent screening
- Heavy metal testing.
Q: Is nefiracetam safe for daily long-term use?
A: While no long-term human trials exist specifically for nootropic use of nefiracetam, animal studies spanning up to 12 months have demonstrated excellent tolerability. Most users cycle (5 days on, 2 days off) as a conservative approach.
Q: How quickly will I notice effects?
A: Some users report subtle effects within the first day, but most notice the full spectrum of benefits within 3–7 days of consistent dosing. This is typical for racetams, which work through receptor modulation rather than receptor agonism (like a stimulant).
Q: Can I mix it with coffee or pre-workout?
A: Generally yes, but start with half your normal caffeine dose. Nefiracetam’s AMPA enhancement can amplify caffeine’s stimulant effects. Some users find the combination synergistic; others find it overstimulating.
Q: Is nefiracetam a controlled substance?
A: No. Nefiracetam is unscheduled in the United States, the United Kingdom, and most jurisdictions. However, it is restricted in some countries (notably Australia and certain EU member states). Verify your local regulations before ordering.
Q: Will I experience withdrawal if I stop?
A: Nefiracetam does not produce physical dependence in animal models. Users generally discontinue without withdrawal symptoms, though some report a subtle “return to baseline” over several days.
Q: Does it require a choline source?
A: Not strictly, but co-administering with a choline source (Alpha-GPC 300 mg or Citicoline 250 mg) can prevent racetam-associated headaches and support the cholinergic demand.
The Bottom Line
Nefiracetam stands apart in the racetam family as the only compound that meaningfully addresses both cognitive enhancement and anxiety simultaneously. Its dual modulation of AMPA and GABA_A receptors offers a balanced, sustainable form of cognitive support that many users describe as “clear-headed calm.”
For researchers and enthusiasts interested in the intersection of nootropics and neuroprotection, nefiracetam represents a uniquely well-studied option with a mechanism of action that continues to fascinate neuroscientists.
This information is provided for educational and research purposes only. Nefiracetam is not approved by the FDA for the treatment of any medical condition. Consult with a qualified healthcare provider before beginning any new supplement regimen, especially if you are pregnant, nursing, taking medication, or have a medical condition.
Product Specifications:
SKU: NEF-XG
Batch: (see label)
Certificate of Analysis: See next tab.
Related products
Bemethyl Free Base
From €44.80J147
From €49.80Piracetam
From €29.80Pramiracetam
From €28.80Sulbutiamine
From €26.80Uridine
From €24.80Lab Analysis
Chemical Informations
| Property | Details |
|---|---|
| Compound Name | Nefiracetam |
| CAS Number | 77191-36-7 |
| Molecular Formula | C14H18N2O2 |
| Molecular Weight | 246.31 g/mol |
| IUPAC Name | N-(2,6-dimethylphenyl)-2-(2-oxopyrrolidin-1-yl)acetamide |
| SMILES | CC1=CC=C(C=C1)NC(=O)CN2CCCC2=O |
Storage Conditions
| Property | Details |
|---|---|
| Temperature | Store at 20-25°C (room temperature) |
| Environment | Cool, dry place |
| Protection | Keep away from moisture and light |
| Form | Powder for research use |

